# Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion in Adults Receiving Venovenous ECMO With a Heparin Bonded Circuit.

> **NCT02966080** · NA · WITHDRAWN · sponsor: **University of Arizona**

## Conditions studied

- Acute Respiratory Failure
- Extracorporeal Membrane Oxygenation Complication
- Bleeding

## Interventions

- **DRUG:** HEP-IV

## Key facts

- **NCT ID:** NCT02966080
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-12
- **Primary completion:** 2020-12
- **Final completion:** 2021-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled, study will not be conducted.
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02966080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02966080, "Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion in Adults Receiving Venovenous ECMO With a Heparin Bonded Circuit.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02966080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*